SAMANTHA KITCOFF: Open Payments
NPI 1477925071 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,487 in 277 payments from 18 companies in 2025. Trend: 2023 $3,281 · 2024 $2,762 · 2025 $3,487
Food & beverage: $3,487
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 50 | $472 |
| Galderma Laboratories, L.P. | 35 | $376 |
| ABBVIE INC. | 27 | $362 |
| UCB, Inc. | 29 | $326 |
| PFIZER INC. | 22 | $294 |
| Novartis Pharmaceuticals Corporation | 27 | $289 |
| Janssen Biotech, Inc. | 11 | $187 |
| Organon LLC | 13 | $167 |
| LEO Pharma Inc. | 16 | $165 |
| Amgen Inc. | 8 | $165 |
Products named: Bimzelx, CIBINQO, DUPIXENT, SKYRIZI, NEMLUVIO, TREMFYA, AKLIEF, OTEZLA.
Industry payments across IN — which companies pay providers there.
